6NNA

Human Fatty Acid Synthase Psi/KR Tri-Domain with NADPH and Compound 22


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.26 Å
  • R-Value Free: 0.251 
  • R-Value Work: 0.201 

wwPDB Validation 3D Report Full Report


This is version 1.2 of the entry. See complete history

Literature

Discovery and optimization of novel piperazines as potent inhibitors of fatty acid synthase (FASN).

Martin, M.W.Lancia Jr., D.R.Li, H.Schiller, S.E.R.Toms, A.V.Wang, Z.Bair, K.W.Castro, J.Fessler, S.Gotur, D.Hubbs, S.E.Kauffman, G.S.Kershaw, M.Luke, G.P.McKinnon, C.Yao, L.Lu, W.Millan, D.S.

(2019) Bioorg. Med. Chem. Lett. 29: 1001-1006

  • DOI: 10.1016/j.bmcl.2019.02.012

  • PubMed Abstract: 
  • The discovery, structure-activity relationships, and optimization of a novel class of fatty acid synthase (FASN) inhibitors is reported. High throughput screening identified a series of substituted piperazines with structural features that enable int ...

    The discovery, structure-activity relationships, and optimization of a novel class of fatty acid synthase (FASN) inhibitors is reported. High throughput screening identified a series of substituted piperazines with structural features that enable interactions with many of the potency-driving regions of the FASN KR domain binding site. Derived from this series was FT113, a compound with potent biochemical and cellular activity, which translated into excellent activity in in vivo models.


    Organizational Affiliation

    FORMA Therapeutics, 500 Arsenal Street, Suite 100, Watertown, MA 02472, USA.,FORMA Therapeutics, 35 Northeast Industrial Road, Branford, CT 06405, USA.,FORMA Therapeutics, 500 Arsenal Street, Suite 100, Watertown, MA 02472, USA. Electronic address: mmartin@formatherapeutics.com.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Fatty acid synthase,Fatty acid synthase
A, B
660Homo sapiensMutation(s): 2 
Gene Names: FASN (FAS)
EC: 2.3.1.85
Find proteins for P49327 (Homo sapiens)
Go to Gene View: FASN
Go to UniProtKB:  P49327
Small Molecules
Ligands 3 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
EDO
Query on EDO

Download SDF File 
Download CCD File 
A, B
1,2-ETHANEDIOL
ETHYLENE GLYCOL
C2 H6 O2
LYCAIKOWRPUZTN-UHFFFAOYSA-N
 Ligand Interaction
KUA
Query on KUA

Download SDF File 
Download CCD File 
A, B
{4-[4-(1,3-benzoxazol-2-yl)benzene-1-carbonyl]piperazin-1-yl}(1-hydroxycyclopropyl)methanone
C22 H21 N3 O4
FGXGECPNCZCUAJ-UHFFFAOYSA-N
 Ligand Interaction
NDP
Query on NDP

Download SDF File 
Download CCD File 
A, B
NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE
C21 H30 N7 O17 P3
ACFIXJIJDZMPPO-NNYOXOHSSA-N
 Ligand Interaction
Modified Residues  1 Unique
IDChainsTypeFormula2D DiagramParent
CAF
Query on CAF
A, B
L-PEPTIDE LINKINGC5 H12 As N O3 SCYS
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.26 Å
  • R-Value Free: 0.251 
  • R-Value Work: 0.201 
  • Space Group: P 1
Unit Cell:
Length (Å)Angle (°)
a = 48.110α = 65.57
b = 85.740β = 90.00
c = 86.470γ = 87.00
Software Package:
Software NamePurpose
Aimlessdata scaling
REFMACrefinement
PDB_EXTRACTdata extraction
XDSdata reduction
PHASERphasing

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

Revision History 

  • Version 1.0: 2019-02-20
    Type: Initial release
  • Version 1.1: 2019-03-13
    Type: Data collection, Database references
  • Version 1.2: 2019-03-20
    Type: Data collection, Database references